Source disclosure: February 26, 2026, 16:00 JST
Yuki Gosei Kogyo Co.,Ltd. [4531.T]
TOKYO, Feb 26 (Pulse News Wire) – Yuki Gosei Kogyo CO.,LTD. (4531.T) announced today its collaboration with Hodogaya Chemical Industry Co., Ltd.
To develop nucleic acid pharmaceutical manufacturing services. The partnership aims to integrate Hodogaya's expertise in raw materials and research-grade oligonucleotide synthesis with Yuki Gosei Kogyo’s advanced manufacturing and quality management capabilities to offer comprehensive solutions from raw materials to GMP production. Under the agreement, Hodogaya Chemical Industry plans to acquire 1,000,000 ordinary shares (approximately 10% of outstanding shares) of Yuki Gosei Kogyo.
The transaction is expected to enhance the companies' ability to serve academic institutions and pharmaceutical firms globally while ensuring safe and reliable supply of active pharmaceutical ingredients. This collaboration does not anticipate impacting Yuki Gosei Kogyo's fiscal year 2026 operating results. Hodogaya Chemical Industry, established on December 11, 1916, operates out of Tokyo, Minato Ku Higashishinbashi Ichi Choume and specializes in functional pigments, resins, basic chemicals, and related products.
The company boasts a capital of ¥11.20 billion.
AI-translated content. 🟢 Confidence: High See terms • Original filing